← Open Payments lookup

ELIZABETH NAROUZ: Open Payments

NPI 1033687389 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$476 in 19 payments from 8 companies in 2025. Trend: 2023 $107 · 2024 $392 · 2025 $476

Food & beverage: $449Education: $27
CompanyPaymentsAmount
Ardelyx, Inc.7$191
Novo Nordisk Inc2$65
AstraZeneca Pharmaceuticals LP2$56
AKEBIA THERAPEUTICS INC2$51
Novartis Pharmaceuticals Corporation2$50
OPKO Pharmaceuticals, LLC1$26
Boehringer Ingelheim Pharmaceuticals, Inc.1$19
Travere Therapeutics, Inc.2$19

Products named: IBSRELA, FARXIGA, Vafseo, Fabhalta, Wegovy, Ozempic, RAYALDEE, JARDIANCE.

Industry payments across DC — which companies pay providers there.